Association of serum bisphenol A with hypertension in thai population

International Journal of Hypertension

Volumn 2015, Issue , 2015, Pages

  Aekplakorn, Wichai ^a   Chailurkit, La Or ^a   Ongphiphadhanakul, Boonsong ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANTIHYPERTENSIVE AGENT; ESTRADIOL; ESTROGEN;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BODY MASS; CHEMILUMINESCENCE ANALYZER; CHEMOLUMINESCENCE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MALE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; SMOKING; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; THAI (PEOPLE);

EID: 84924268342     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2015/594189     Document Type: Article

References (33)

1. A. M. Calafat,X. Ye, L.-Y. Wong, J. A. Reidy, andL. L. Needham, "Exposure of the U. S. population to Bisphenol A and 4-tertiaryoctylphenol: 2003-2004," Environmental Health Perspectives, vol. 116, no. 1, pp. 39-44, 2008.
2. Z. Zhang, H. Alomirah, H.-S. Cho et al. , "Urinary bisphenol a concentrations and their implications for human exposure in severalAsian countries," Environmental Science and Technology, vol. 45, no. 16, pp. 7044-7050, 2011.
3. W. Aekplakorn, L. O. Chailurkit, and B. Ongphiphadhanakul, "Relationship of serum bisphenol A with diabetes in the Thai population, National Health Examination Survey IV, 2009," Journal of Diabetes, vol. 7, no. 2, pp. 240-249, 2014.
4. F. S. vomSaal, B. T. Akingbemi, S. M. Belcher et al. , "Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure," Reproductive Toxicology, vol. 24, no. 2, pp. 131-138, 2007.
5. H. Hiroi, O. Tsutsumi, M. Momoeda, Y. Takai, Y. Osuga, and Y. Taketani, "Differential interactions of bisphenol A and 17betaestradiol with estrogen receptor (ERalpha) and ERbeta," Endocrine Journal, vol. 46, no. 6, pp. 773-778, 1999.
6. C. Sriphrapradang, L.-O. Chailurkit, W. Aekplakorn, and B. Ongphiphadhanakul, "Association between bisphenol A and abnormal free thyroxine level in men," Endocrine, vol. 44, no. 2, pp. 441-447, 2013.
7. R. Ahmadkhaniha, M. Mansouri, M. Yunesian et al. , "Association of urinary bisphenol a concentration with type-2 diabetes mellitus," Journal of EnvironmentalHealth Science and Engineering, vol. 12, no. 1, p. 64, 2014.
8. K. Kim and H. Park, "Association between urinary concentrations of bisphenol A and type 2 diabetes in Korean adults: a population-based cross-sectional study," International Journal of Hygiene and Environmental Health, vol. 216, no. 4, pp. 467-471, 2013.
9. A. Shankar and S. Teppala, "Relationship between urinary bisphenol A levels and diabetes mellitus," Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 12, pp. 3822-3826, 2011.
10. G. Ning, Y. Bi, T. Wang et al. , "Relationship of urinary bisphenol A concentration to risk for prevalent type 2 diabetes in Chinese adults: a cross-sectional analysis," Annals of Internal Medicine, vol. 155, no. 6, pp. 368-374, 2011.
11. C. Sabanayagam, S. Teppala, and A. Shankar, "Relationship between urinary bisphenol A levels and prediabetes among subjects free of diabetes," Acta Diabetologica, vol. 50, no. 4, pp. 625-631, 2013.
12. R. R. Newbold, E. Padilla-Banks, and W. N. Jefferson, "Environmental estrogens and obesity," Molecular and Cellular Endocrinology, vol. 304, no. 1-2, pp. 84-89, 2009.
13. D. Melzer, N. J. Osborne,W. E. Henley et al. , "Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women," Circulation, vol. 125, no. 12, pp. 1482-1490, 2012.
14. D. Melzer, N. E. Rice,C. Lewis,W. E. Henley, andT. S. Galloway, "Association of urinary bisphenol A concentration with heart disease: evidence from NHANES 2003/06," PLoS ONE, vol. 5, no. 1, Article ID e8673, 2010.
15. I. A. Lang, T. S. Galloway, A. Scarlett et al. , "Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults,"The Journal of theAmerican Medical Association, vol. 300, no. 11, pp. 1303-1310, 2008.
16. S. Bae, J. H. Kim, Y.-H. Lim, H. Y. Park, and Y.-C. Hong, "Associations of bisphenolAexposurewith heart rate variability and blood pressure," Hypertension, vol. 60, no. 3, pp. 786-793, 2012.
17. A. Shankar and S. Teppala, "Urinary bisphenol A and hypertension in a multiethnic sample of US adults," Journal of Environmental and Public Health, vol. 2012,Article ID481641, 5 pages, 2012.
18. The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration, "Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment," The LancetDiabetes & Endocrinology, vol. 2, no. 8,pp. 634-647, 2014.
19. G. Mancia, R. Fagard, K. Narkiewicz et al. , "2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)," Journal of Hypertension, vol. 31, no. 7, pp. 1281-1357, 2013.
20. M. E. Mendelsohn and R. H. Karas, "Molecular and cellular basis of cardiovascular gender differences," Science, vol. 308, no. 5728, pp. 1583-1587, 2005.
21. E. Murphy, "Estrogen signaling and cardiovascular disease," Circulation Research, vol. 109, no. 6, pp. 687-696, 2011.
22. W. Aekplakorn, R. Sangthong, P. Kessomboon et al. , "Changes in prevalence, awareness, treatment and control of hypertension inThai population, 2004-2009:Thai NationalHealth Examination Survey III-IV," Journal of Hypertension, vol. 30, no. 9, pp. 1734-1742, 2012.
23. T. G. Pickering, J. E. Hall, L. J. Appel et al. , "Recommendations for blood pressure measurement in humans: an AHA scientific statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee," Journal of Clinical Hypertension (Greenwich), vol. 7, no. 2, pp. 102-109, 2005.
24. Centers for Disease Control and Prevention (CDC), "Cigarette smoking among adults-United States, 1992, and changes in the definition of current cigarette smoking,"MMWR. Morbidity and MortalityWeekly Report, vol. 43, pp. 342-346, 1992.
25. B. S. Rubin and A. M. Soto, "Bisphenol A: perinatal exposure and body weight," Molecular and Cellular Endocrinology, vol. 304, no. 1-2, pp. 55-62, 2009.
26. X.-J. Du, R. A. Riemersma, and A. M. Dart, "Cardiovascular protection by oestrogen is partlymediated throughmodulation of autonomic nervous function," Cardiovascular Research, vol. 30, no. 2, pp. 161-165, 1995.
27. T. Pelzer, V. Jazbutyte, K. Hu et al. , "The estrogen receptor-agonist 16-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats," Cardiovascular Research, vol. 67, no. 4, pp. 604-612, 2005.
28. I. Nikolic, D. Liu, J. A. Bell, J. Collins, C. Steenbergen, and E. Murphy, "Treatment with an estrogen receptor-beta-selective agonist is cardioprotective," Journal of Molecular and Cellular Cardiology, vol. 42, no. 4, pp. 769-780, 2007.
29. D. H. P. Streeten, G. H. Anderson Jr. , T. Howland, R. Chiang, andH. Smulyan, "Effects of thyroid function on blood pressure. Recognition of hypothyroid hypertension," Hypertension, vol. 11, no. 1, pp. 78-83, 1988.
30. H. Ooe, T. Taira, S. M. M. Iguchi-Ariga, and H. Ariga, "Induction of reactive oxygen species by bisphenolAand abrogation of bisphenol A-induced cell injury by DJ-1," Toxicological Sciences, vol. 88, no. 1, pp. 114-126, 2005.
31. J. R. Sowers, "Insulin resistance and hypertension," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 286, no. 5, pp. H1597-H1602, 2004.
32. J. G. Teeguarden, A. M. Calafat, X. Ye et al. , "Twenty-four hour human urine and serum profiles of bisphenol A during highdietary exposure," Toxicological Sciences, vol. 123, no. 1, pp. 48-57, 2011.
33. J. Teeguarden, S. Hanson-Drury, J. W. Fisher, and D. R. Doerge, "Are typical human serum BPA concentrations measurable and sufficient to be estrogenic in the general population?" Food and Chemical Toxicology, vol. 62, pp. 949-963, 2013.